Complete Filing Data
HOOKIPA Pharma Inc. reported Net Income Loss of -$81.58 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean HOOKIPA Pharma Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$43.5M | -$81.6M | -$64.9M | -$75.7M | -$44.1M | -$43.0M | -$16.2M | -$12.7M |
| Revenue From Contract With Customer Excluding Assessed Tax | $43.9M | $20.1M | $14.2M | $18.4M | $19.6M | $11.9M | $7.6M | |
| Research And Development Expense | $68.5M | $86.4M | $68.6M | $82.9M | $54.8M | $46.3M | $22.0M | $9.8M |
| Other Nonoperating Income Expense | -$3.2M | $313.0K | -$392.0K | -$2.8M | $3.1M | $601.0K | $133.0K | -$25.0K |
| Operating Income Loss | -$51.5M | -$97.7M | -$73.2M | -$81.7M | -$53.3M | -$51.1M | -$21.2M | -$14.2M |
| Nonoperating Income Expense | $7.8M | $16.5M | $8.5M | $6.0M | $9.2M | $8.0M | $5.0M | $1.4M |
| Income Tax Expense Benefit | -$106.0K | $368.0K | $230.0K | $1.0K | $0.00 | $0.00 | $24.0K | $4.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$43.6M | -$81.2M | -$64.7M | -$75.7M | -$44.1M | -$43.0M | -$16.2M | -$12.7M |
| General And Administrative Expense | $20.2M | $18.6M | $18.8M | $17.3M | $18.1M | $16.7M | $6.8M | $4.4M |
| Comprehensive Income Net Of Tax | -$40.7M | -$82.4M | -$67.3M | -$74.4M | -$45.5M | -$44.0M | -$18.6M | -$11.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $1.3M | -$1.4M | -$933.0K | -$2.4M | $1.8M | |||
| Interest Expense | $317.0K | $687.0K | $898.0K | $786.0K | $877.0K | $778.0K | $606.0K | |
| Income Taxes Paid Net | $1.0K | $403.0K | $1.0K | $1.0K | $0.00 | $24.0K | $4.0K | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $2.8M | -$777.0K | -$2.4M | $1.3M | -$1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$15.4M | -$13.8M | -$19.1M | $14.4M | -$19.1M | -$18.0M | -$19.7M | -$18.3M | -$16.4M | -$18.0M | -$20.0M | -$17.2M | -$17.2M | -$12.5M | -$13.6M | -$7.1M | -$10.9M | -$10.2M | -$11.4M | -$12.1M | -$9.3M | -$1.9M | -$4.0M | -$5.8M | -$4.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $2.0M | $4.7M | $1.3M | $36.6M | $6.9M | $2.7M | $3.2M | $2.2M | $2.7M | $1.4M | $3.9M | $5.4M | $5.3M | $5.2M | $4.0M | $6.7M | $3.7M | $3.6M | $2.0M | $4.1M | $2.2M | $5.1M | $1.9M | $649.0K | |
| Research And Development Expense | $12.9M | $15.6M | $19.7M | $20.2M | $24.6M | $19.7M | $20.9M | $18.3M | $16.1M | $16.6M | $20.7M | $19.6M | $20.2M | $16.0M | $11.6M | $11.5M | $11.0M | $13.9M | $10.2M | $6.2M | $6.2M | $5.0M | |||
| Other Nonoperating Income Expense | $2.0M | $1.8M | -$218.0K | -$285.0K | -$833.0K | $25.0K | -$220.0K | $202.0K | $163.0K | $528.0K | -$1.1M | -$158.0K | -$58.0K | $994.0K | $646.0K | -$24.0K | $604.0K | -$195.0K | $283.0K | $33.0K | -$36.0K | $22.0K | |||
| Operating Income Loss | -$17.9M | -$18.6M | -$22.5M | $11.1M | -$22.7M | -$21.5M | -$22.7M | -$21.0M | -$18.4M | -$20.1M | -$21.2M | -$19.3M | -$19.2M | -$16.4M | -$9.2M | -$12.5M | -$13.6M | -$13.6M | -$10.7M | -$5.6M | -$7.0M | -$6.4M | |||
| Nonoperating Income Expense | $2.4M | $4.8M | $3.4M | $3.3M | $3.6M | $3.5M | $3.2M | $2.7M | $2.1M | $2.2M | $1.1M | $2.1M | $1.9M | $2.8M | $2.1M | $1.5M | $2.2M | $1.7M | $1.3M | $1.6M | $1.2M | $1.9M | |||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $205.0K | $0.00 | $1.0K | $0.00 | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $9.0K | $100.0K | $0.00 | $2.0K | $1.0K | -$24.0K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$15.4M | -$13.8M | -$19.1M | $14.4M | -$19.1M | -$18.0M | -$19.5M | -$18.3M | -$16.4M | -$18.0M | -$20.0M | -$17.2M | -$17.2M | -$13.6M | -$7.1M | -$10.9M | -$11.4M | -$12.0M | -$9.3M | -$4.0M | -$5.8M | -$4.5M | |||
| General And Administrative Expense | $6.9M | $6.7M | $3.9M | $4.1M | $4.9M | $4.4M | $4.9M | $4.9M | $5.0M | $5.0M | $4.3M | $5.1M | $4.3M | $4.4M | $4.3M | $4.6M | $4.6M | $3.8M | $2.7M | $1.3M | $1.4M | $1.5M | |||
| Comprehensive Income Net Of Tax | -$16.8M | -$15.2M | -$18.9M | $14.9M | -$17.9M | -$18.1M | -$19.7M | -$19.6M | -$17.4M | -$18.5M | -$19.6M | -$16.9M | -$17.7M | -$13.9M | -$7.2M | -$11.0M | -$12.1M | -$11.8M | -$10.1M | -$4.2M | -$8.8M | -$3.0M | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.4M | -$1.0M | -$487.0K | $471.0K | $293.0K | -$476.0K | -$309.0K | -$133.0K | -$93.0K | -$763.0K | $300.0K | -$736.0K | -$243.0K | -$3.0M | $1.5M | ||||||||||
| Interest Expense | $2.0K | $49.0K | $97.0K | $122.0K | $105.0K | $231.0K | $243.0K | $234.0K | $218.0K | $219.0K | $194.0K | $166.0K | $227.0K | $227.0K | $210.0K | $213.0K | $194.0K | $191.0K | $193.0K | ||||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$1.0K | ||||||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$1.4M | -$1.4M | $178.0K | $531.0K | $1.2M | -$69.0K | -$17.0K | -$1.4M | -$1.0M | -$487.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $102.5M | $89.6M | $156.1M | $117.9M | -$60.4M | -$42.7M | -$32.5M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $113.4M | $66.9M | $143.2M | $113.6M | $48.6M | $61.4M | $13.2M | ||
| Repayments Of Debt | $1.1M | $1.8M | $2.8M | $0.00 | $1.3M | $842.0K | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $117.1M | $112.5M | $65.9M | $142.7M | $113.2M | $48.6M | |||
| Retained Earnings Accumulated Deficit | -$369.3M | -$287.7M | -$222.8M | -$147.1M | -$103.0M | -$60.0M | |||
| Property Plant And Equipment Net | $7.7M | $18.0M | $16.4M | $6.2M | $5.1M | $4.3M | |||
| Other Liabilities Noncurrent | $6.0M | $3.4M | $2.6M | $1.4M | $2.2M | $3.1M | |||
| Liabilities Noncurrent | $29.5M | $32.3M | $8.8M | $10.6M | $11.1M | $9.2M | |||
| Liabilities Current | $42.0M | $35.6M | $27.7M | $21.1M | $14.8M | $14.7M | |||
| Liabilities And Stockholders Equity | $161.3M | $170.5M | $126.0M | $187.8M | $143.7M | $68.3M | |||
| Liabilities | $71.5M | $67.9M | $36.5M | $31.7M | $25.8M | $23.9M | |||
| Assets Noncurrent | $14.2M | $23.3M | $23.9M | $16.3M | $15.7M | $5.9M | |||
| Assets Current | $147.1M | $147.2M | $102.1M | $171.5M | $128.0M | $62.3M | |||
| Assets | $161.3M | $170.5M | $126.0M | $187.8M | $143.7M | $68.3M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$7.9M | -$7.2M | -$4.8M | -$6.1M | -$4.7M | -$3.7M | |||
| Accrued Expenses And Other Current Liabilities | $12.1M | $11.2M | $8.9M | $7.4M | $8.4M | $4.4M | |||
| Accounts Receivable Net Current | $511.0K | $6.5M | $6.9M | $5.5M | $1.5M | $4.9M | |||
| Accounts Payable Current | $12.5M | $5.5M | $8.8M | $8.0M | $944.0K | $3.7M | |||
| Operating Lease Right Of Use Asset | $5.5M | $4.0M | $5.7M | $6.5M | $7.9M | ||||
| Operating Lease Liability Noncurrent | $3.8M | $2.3M | $3.9M | $3.8M | $5.3M | ||||
| Restricted Cash Noncurrent | $425.0K | $419.0K | $425.0K | $434.0K | $424.0K | ||||
| Receivables Tax Research Premium Current | $18.8M | $15.5M | $14.3M | $15.1M | $8.2M | $2.3M | |||
| Operating Lease Liability Current | $1.6M | $1.7M | $1.7M | $2.0M | $1.8M | ||||
| Prepaid Expenses And Other Current Assets | $12.2M | $14.5M | $8.1M | $5.1M | $6.5M | ||||
| Other Assets Noncurrent | $863.0K | $1.4M | $1.9M | $701.0K | $1.6M | ||||
| Contract With Customer Liability Noncurrent | $25.7M | $21.0K | $784.0K | $72.0K | $1.7M | ||||
| Contract With Customer Liability Current | $15.7M | $5.5M | $3.8M | $3.6M | $6.6M | ||||
| Loans Payable | $911.0K | $2.2M | $4.5M | $3.5M | $4.4M | ||||
| Finance Lease Principal Payments | $25.0K | $438.0K | $108.0K | $1.4M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $47.3M | -$78.8M | $31.7M | $66.0M | -$10.3M | $45.7M | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Property And Equipment Additions In Accounts Payable And Accrued Expenses | $56.0K | $742.0K | -$16.0K | $10.0K | -$545.0K | -$533.0K | |||
| Loans Payable Current | $1.1M | $1.6M | $2.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $34.1M | $51.2M | $71.8M | $86.1M | $104.5M | $89.9M | $95.1M | $112.3M | $83.5M | $113.3M | $132.0M | $147.9M | $108.1M | $125.9M | $140.1M | $92.2M | $103.9M | $109.0M | $125.8M | $136.0M | -$70.1M | -$58.1M | -$54.1M | -$45.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $40.5M | $39.9M | $60.0M | $77.4M | $93.0M | $117.5M | $108.1M | $136.0M | $110.0M | $100.7M | $118.9M | $141.8M | $82.7M | $103.0M | $128.1M | $82.3M | $93.3M | $104.9M | $124.0M | $135.2M | $70.5M | $55.8M | $63.4M | ||
| Repayments Of Debt | $1.1M | $0.00 | $1.2M | $597.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.3M | $0.00 | $0.00 | $0.00 | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $40.3M | $39.7M | $59.8M | $77.2M | $92.8M | $107.7M | $135.6M | $109.6M | $99.8M | $117.9M | $140.8M | $82.3M | $102.5M | $127.7M | $81.8M | $92.9M | $104.5M | $123.7M | $134.9M | $70.5M | $64.8M | $61.4M | |||
| Retained Earnings Accumulated Deficit | -$428.2M | -$412.8M | -$387.8M | -$374.0M | -$354.9M | -$344.4M | -$325.4M | -$307.4M | -$275.4M | -$257.1M | -$240.7M | -$201.5M | -$181.5M | -$164.3M | -$134.6M | -$121.0M | -$113.9M | -$92.8M | -$81.4M | -$69.3M | |||||
| Property Plant And Equipment Net | $98.0K | $179.0K | $6.9M | $7.0M | $7.3M | $20.2M | $18.2M | $18.0M | $16.5M | $17.0M | $17.1M | $15.4M | $13.2M | $6.2M | $6.1M | $6.0M | $5.4M | $4.6M | $4.6M | $4.5M | |||||
| Other Liabilities Noncurrent | $9.7M | $5.6M | $6.1M | $5.8M | $5.9M | $3.3M | $3.4M | $3.1M | $2.1M | $2.2M | $2.5M | $3.0M | $1.4M | $1.7M | $1.6M | $1.8M | $2.0M | $2.6M | $3.0M | $3.3M | |||||
| Liabilities Noncurrent | $10.5M | $6.7M | $9.4M | $11.1M | $11.8M | $28.4M | $32.5M | $35.4M | $12.1M | $13.0M | $16.6M | $7.4M | $6.3M | $9.8M | $10.4M | $10.8M | $11.6M | $13.3M | $14.7M | $14.9M | |||||
| Liabilities Current | $16.6M | $24.7M | $28.6M | $27.8M | $29.5M | $40.6M | $46.2M | $44.2M | $26.1M | $27.2M | $31.2M | $26.6M | $33.9M | $20.1M | $18.7M | $18.6M | $15.4M | $13.0M | $17.4M | $15.1M | |||||
| Liabilities And Stockholders Equity | $61.3M | $82.5M | $109.7M | $125.0M | $145.9M | $164.0M | $191.1M | $163.1M | $151.5M | $172.2M | $195.7M | $142.2M | $166.2M | $169.9M | $121.3M | $133.3M | $136.0M | $152.0M | $168.1M | $102.0M | |||||
| Liabilities | $27.2M | $31.3M | $37.9M | $39.0M | $41.3M | $69.0M | $78.8M | $79.6M | $38.2M | $40.3M | $47.8M | $34.1M | $40.2M | $29.9M | $29.1M | $29.4M | $27.0M | $26.3M | $32.1M | $30.0M | |||||
| Assets Noncurrent | $1.2M | $1.9M | $16.6M | $17.7M | $13.2M | $24.5M | $23.0M | $23.2M | $21.9M | $23.1M | $24.6M | $23.6M | $22.7M | $16.6M | $15.5M | $15.4M | $15.3M | $15.7M | $17.0M | $17.1M | |||||
| Assets Current | $60.1M | $80.7M | $93.2M | $107.4M | $132.7M | $139.5M | $168.1M | $139.9M | $129.6M | $149.1M | $171.1M | $118.6M | $143.5M | $153.3M | $105.8M | $117.9M | $120.7M | $136.4M | $151.1M | $84.9M | |||||
| Assets | $61.3M | $82.5M | $109.7M | $125.0M | $145.9M | $164.0M | $191.1M | $163.1M | $151.5M | $172.2M | $195.7M | $142.2M | $166.2M | $169.9M | $121.3M | $133.3M | $136.0M | $152.0M | $168.1M | $102.0M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$6.4M | -$5.1M | -$8.6M | -$7.2M | -$7.4M | -$6.0M | -$7.2M | -$7.2M | -$7.6M | -$6.3M | -$5.3M | -$5.8M | -$6.3M | -$6.5M | -$5.2M | -$4.9M | -$4.7M | -$4.9M | -$4.2M | -$4.5M | |||||
| Accrued Expenses And Other Current Liabilities | $9.0M | $10.7M | $13.1M | $10.9M | $10.9M | $13.1M | $12.3M | $14.3M | $7.8M | $8.7M | $8.7M | $9.5M | $15.4M | $6.9M | $8.7M | $5.4M | $4.2M | $5.2M | $7.1M | $5.4M | |||||
| Accounts Receivable Net Current | $545.0K | $290.0K | $324.0K | $82.0K | $10.2M | $675.0K | $255.0K | $501.0K | $743.0K | $1.2M | $703.0K | $2.5M | $4.9M | $4.3M | $3.0M | $4.7M | $2.8M | $1.3M | $3.3M | $1.3M | |||||
| Accounts Payable Current | $3.7M | $8.7M | $9.0M | $11.3M | $11.2M | $8.9M | $11.6M | $7.1M | $7.8M | $5.6M | $6.7M | $10.1M | $10.9M | $8.1M | $4.4M | $7.0M | $4.0M | $3.5M | $5.1M | $3.3M | |||||
| Operating Lease Right Of Use Asset | $588.0K | $885.0K | $2.9M | $5.0M | $5.0M | $2.9M | $3.3M | $3.7M | $4.0M | $4.7M | $5.3M | $4.7M | $5.3M | $5.7M | $6.7M | $6.9M | $7.3M | $8.1M | $8.9M | $8.9M | |||||
| Operating Lease Liability Noncurrent | $284.0K | $323.0K | $1.6M | $3.4M | $3.4M | $1.3M | $1.7M | $2.0M | $2.5M | $3.0M | $3.6M | $2.3M | $2.8M | $3.3M | $4.1M | $4.4M | $4.8M | $5.6M | $6.2M | $6.3M | |||||
| Restricted Cash Noncurrent | $104.0K | $104.0K | $207.0K | $203.0K | $204.0K | $419.0K | $422.0K | $421.0K | $410.0K | $418.0K | $423.0K | $428.0K | $430.0K | $429.0K | $429.0K | $425.0K | $423.0K | $320.0K | $320.0K | ||||||
| Receivables Tax Research Premium Current | $7.8M | $23.4M | $24.7M | $22.5M | $20.6M | $22.4M | $20.2M | $18.0M | $17.3M | $16.5M | $15.6M | $17.9M | $16.0M | $13.6M | $13.2M | $11.0M | $9.3M | ||||||||
| Operating Lease Liability Current | $312.0K | $552.0K | $1.2M | $1.5M | $1.6M | $1.5M | $1.6M | $1.7M | $1.6M | $1.6M | $1.7M | $1.9M | $2.0M | $1.9M | $1.9M | $1.8M | $1.8M | ||||||||
| Prepaid Expenses And Other Current Assets | $9.2M | $10.7M | $8.7M | $12.1M | $11.9M | $11.3M | $13.0M | $13.4M | $15.9M | $20.0M | $7.7M | $7.8M | $9.3M | $4.2M | $11.4M | $13.0M | $13.1M | ||||||||
| Other Assets Noncurrent | $660.0K | $581.0K | $1.1M | $1.0M | $1.1M | $952.0K | $1.1M | $1.8M | $2.2M | $2.8M | $3.1M | $823.0K | $572.0K | $642.0K | $2.6M | $3.2M | $3.6M | ||||||||
| Contract With Customer Liability Noncurrent | $2.6M | $19.7M | $23.7M | $27.4M | $30.3M | $6.8M | $7.0M | $8.7M | $29.0K | $31.0K | $272.0K | $466.0K | $760.0K | $1.3M | $377.0K | $715.0K | $823.0K | ||||||||
| Contract With Customer Liability Current | $4.6M | $14.6M | $16.1M | $19.7M | $19.0M | $7.5M | $9.8M | $10.7M | $2.4M | $3.0M | $3.2M | $3.6M | $4.4M | $5.4M | $4.2M | $5.2M | $6.4M | ||||||||
| Loans Payable | $800.0K | $819.0K | $1.8M | $2.2M | $2.1M | $4.6M | $4.2M | $3.8M | $3.6M | $4.8M | $4.8M | $4.5M | |||||||||||||
| Finance Lease Principal Payments | $20.0K | $24.0K | $36.0K | $1.4M | |||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.9M | $75.2M | -$14.6M | -$8.6M | $22.7M | ||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Property And Equipment Additions In Accounts Payable And Accrued Expenses | -$22.0K | $504.0K | $398.0K | $539.0K | |||||||||||||||||||||
| Loans Payable Current | $1.1M | $1.0M | $1.0M | $2.1M | $1.4M | $1.4M | $3.4M | $2.7M | $2.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $2.0M | $2.3M | $5.0M | $7.6M | $8.7M | $5.6M | $867.0K | $770.0K |
| Payments To Acquire Property Plant And Equipment | $194.0K | $4.2M | $5.0M | $12.6M | $2.4M | $2.0M | $2.2M | $1.3M |
| Net Cash Provided By Used In Operating Activities | -$77.0M | -$57.5M | -$20.0M | -$66.0M | -$39.3M | -$41.7M | -$15.0M | -$11.9M |
| Net Cash Provided By Used In Investing Activities | -$194.0K | -$4.2M | -$5.0M | -$12.6M | -$2.4M | -$2.0M | -$2.2M | -$1.3M |
| Increase Decrease In Accrued Liabilities And Other Liabilities | -$828.0K | $490.0K | $2.5M | $4.8M | -$184.0K | $5.1M | $1.2M | $1.0M |
| Increase Decrease In Accounts Payable | -$1.6M | $6.5M | -$2.0M | $858.0K | $6.3M | $4.2M | $3.4M | -$1.2M |
| Net Cash Provided By Used In Financing Activities | -$1.3M | $65.7M | $72.3M | -$235.0K | $73.4M | $109.8M | $6.9M | $58.9M |
| Increase Decrease In Contract With Customer Liability | -$27.5M | -$8.3M | $35.5M | $1.4M | $511.0K | -$4.4M | $8.6M | |
| Increase Decrease In Accounts Receivable | -$524.0K | -$6.2M | $341.0K | $1.9M | $3.6M | $3.6M | $5.0M | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $813.0K | $90.0K | -$725.0K | $2.6M | -$2.1M | -$1.0M | -$2.5M | $2.5M |
| Increase Decrease In Prepaid Expenses And Other Current Assets | -$1.7M | -$2.0M | $7.1M | $2.3M | $113.0K | $7.0M | $67.0K | |
| Increase Decrease In Other Noncurrent Assets | -$304.0K | -$424.0K | -$416.0K | $1.1M | -$869.0K | $1.5M | $83.0K | |
| Proceeds From Issuance Of Common Stock | $49.0M | $45.7M | $203.0K | $42.6M | $74.8M | $9.0K | ||
| Depreciation Depletion And Amortization | $2.8M | $3.6M | $3.6M | $4.6M | $4.2M | $3.1M | $640.0K | |
| Increase Decrease In Other Noncurrent Liabilities | $2.7M | $1.5M | -$416.0K | -$142.0K | -$1.1M | |||
| Increase Decrease In Receivable Research Incentives | $6.0M | $2.7M | $2.0M | $295.0K | $5.8M | $5.9M | ||
| Increase Decrease In Operating Lease Liability | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.8M | -$2.4M | ||
| Proceeds From Issuance Of Convertible Preferred Stock | $18.5M | $29.6M | $32.4M | $37.3M | $6.4M | $58.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | -$353.0K | -$249.0K | $658.0K | $1.0M | $1.4M | $1.6M | $1.7M | $2.6M | $1.5M | $2.1M | $2.2M | $2.1M | $1.9M | $1.2M | $383.0K | $205.0K | $206.0K | $206.0K |
| Payments To Acquire Property Plant And Equipment | $20.0K | $116.0K | $274.0K | $1.8M | $330.0K | $199.0K | $400.0K | $262.0K | ||||||||||
| Net Cash Provided By Used In Operating Activities | $52.0K | -$24.2M | -$2.8M | $1.7M | -$14.4M | -$7.1M | -$12.1M | -$5.0M | ||||||||||
| Net Cash Provided By Used In Investing Activities | -$20.0K | -$116.0K | -$274.0K | -$1.8M | -$330.0K | -$199.0K | -$400.0K | -$262.0K | ||||||||||
| Increase Decrease In Accrued Liabilities And Other Liabilities | -$1.9M | -$855.0K | $2.9M | $9.0K | -$263.0K | -$2.9M | -$216.0K | -$483.0K | ||||||||||
| Increase Decrease In Accounts Payable | -$7.2M | -$669.0K | $1.6M | -$1.6M | $444.0K | $2.6M | -$958.0K | -$622.0K | ||||||||||
| Net Cash Provided By Used In Financing Activities | -$135.0K | -$735.0K | $75.3M | $101.0K | -$1.3M | $35.2M | $6.9M | |||||||||||
| Increase Decrease In Contract With Customer Liability | -$1.5M | -$26.3M | $7.2M | $14.1M | -$882.0K | $3.0M | -$935.0K | $0.00 | ||||||||||
| Increase Decrease In Accounts Receivable | $231.0K | $9.4M | -$6.1M | -$6.1M | -$1.1M | $1.3M | -$3.5M | $1.0K | ||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $562.0K | -$159.0K | $434.0K | -$307.0K | -$406.0K | -$87.0K | -$773.0K | |||||||||||
| Increase Decrease In Prepaid Expenses And Other Current Assets | -$992.0K | -$407.0K | -$756.0K | -$73.0K | $361.0K | $3.7M | $889.0K | |||||||||||
| Increase Decrease In Other Noncurrent Assets | $93.0K | $214.0K | $460.0K | $1.3M | -$45.0K | $192.0K | $1.0K | |||||||||||
| Proceeds From Issuance Of Common Stock | $1.0K | $45.7M | $125.0K | $8.0K | ||||||||||||||
| Depreciation Depletion And Amortization | $389.0K | $640.0K | $921.0K | $1.1M | $1.1M | $903.0K | ||||||||||||
| Increase Decrease In Other Noncurrent Liabilities | $3.7M | -$207.0K | $110.0K | $581.0K | ||||||||||||||
| Increase Decrease In Receivable Research Incentives | -$16.2M | $2.2M | $2.2M | $1.7M | -$942.0K | |||||||||||||
| Increase Decrease In Operating Lease Liability | -$322.0K | -$330.0K | -$377.0K | -$421.0K | -$466.0K | |||||||||||||
| Proceeds From Issuance Of Convertible Preferred Stock | $29.6M | $37.3M | $6.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.47 | -$8.63 | -$9.91 | -$2.30 | -$1.69 | -$2.41 | -$17.76 | -$13.95 |
| Earnings Per Share Basic | $-3.47 | $-8.63 | $-9.91 | $-2.30 | $-1.69 | $-2.41 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.23 | -$1.10 | -$1.52 | $1.14 | -$1.73 | -$2.18 | -$0.27 | -$0.25 | -$0.23 | -$0.40 | -$0.61 | -$0.52 | -$0.53 | -$0.46 | -$0.53 | -$0.28 | -$0.43 | -$0.40 | -$0.45 | -$0.63 | -$9.27 | -$2.05 | -$4.34 | -$6.38 | -$5.02 | |
| Earnings Per Share Basic | $-1.23 | $-1.10 | $-1.52 | $1.15 | $-1.73 | $-2.18 | $-0.27 | $-0.25 | $-0.23 | $-0.40 | $-0.61 | $-0.52 | $-0.53 | $-0.53 | ||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.0M | $2.3M | $5.0M | $7.6M | $8.7M | $5.6M | $867.0K | $769.0K |
| Grant Income | $7.4M | $11.2M | $7.9M | $9.7M | $6.5M | $6.7M | $5.6M | $2.1M |
| Investment Income Interest | $3.7M | $5.3M | $1.6M | $27.0K | $400.0K | $1.6M | $0.00 | |
| Costs And Expenses | $95.4M | $117.8M | $87.4M | $100.1M | $72.9M | $63.0M | $28.8M | $14.2M |
| Stock Issued During Period Value Stock Options Exercised | $1.0K | $3.0K | $203.0K | $63.0K | $16.0K | $9.0K | ||
| Other Noncash Income Expense | $0.00 | -$64.0K | -$160.0K | -$1.2M | -$53.0K | -$52.0K | -$7.0K | $45.0K |
| Additional Paid In Capital | $467.1M | $397.3M | $317.1M | $309.3M | $225.6M | $3.3M | ||
| Interest Paid Net | $2.0K | $14.0K | $32.0K | $48.0K | $97.0K | $64.0K | $71.0K | $60.0K |
| Payment Of Financing And Stock Issuance Costs | $135.0K | $149.0K | $195.0K | $224.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -$353.0K | $939.0K | $459.0K | -$249.0K | $574.0K | $696.0K | $658.0K | $1.0M | $1.4M | $1.6M | $1.7M | $2.6M | $1.5M | $2.1M | $2.2M | $2.1M | $1.9M | $1.2M | $383.0K | $205.0K | $206.0K | $206.0K | |
| Grant Income | $227.0K | $2.2M | $2.5M | $2.2M | $2.9M | $2.2M | $2.4M | $2.1M | $2.0M | $1.9M | $2.5M | $2.5M | $2.2M | $2.0M | $1.6M | $1.5M | $1.3M | $1.5M | $1.2M | $1.8M | $1.4M | $2.1M | |
| Investment Income Interest | $236.0K | $809.0K | $1.1M | $1.3M | $1.6M | $1.3M | $1.2M | $535.0K | $182.0K | $7.0K | $7.0K | $7.0K | $7.0K | $20.0K | $59.0K | $312.0K | $565.0K | $511.0K | $64.0K | $0.00 | |||
| Costs And Expenses | $19.9M | $23.3M | $23.7M | $25.5M | $29.5M | $24.2M | $25.8M | $23.2M | $21.2M | $21.6M | $25.0M | $24.7M | $24.5M | $20.4M | $15.9M | $16.2M | $15.6M | $17.7M | $12.9M | $7.5M | |||
| Stock Issued During Period Value Stock Options Exercised | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $112.0K | $125.0K | $16.0K | $7.0K | $8.0K | |||||||||||||
| Other Noncash Income Expense | -$37.0K | -$4.0K | -$74.0K | -$44.0K | -$54.0K | $7.0K | |||||||||||||||||
| Additional Paid In Capital | $468.7M | $469.1M | $468.2M | $467.3M | $466.8M | $445.5M | $444.9M | $398.0M | $396.3M | $395.3M | $393.9M | $315.4M | $313.7M | $310.9M | $232.0M | $229.8M | $227.7M | $223.4M | $221.6M | $3.7M | |||
| Interest Paid Net | $1.0K | $2.0K | |||||||||||||||||||||
| Payment Of Financing And Stock Issuance Costs | $135.0K | $139.0K | $722.0K |
Most recent annual filing with the SEC: February 28, 2025
Data sourced from SEC EDGAR public filings as of August 9, 2026.